Press Releases

Our mission is to bring the best of nature to humankind with new ingredients offerings and more research. For media inquiries or special media assistance, please contact us.

Unigen logo

Press Release – Novel Ingredients Featured at VitaFoods Europe 2022

June 10, 2022

Unigen Inc., showcased its branded ingredient offerings at the recent Vitafoods Europe 2022 in Geneva. Vitafoods Europe is considered the world’s most attended nutraceutical event, attracting over 25,000 industry experts and 1000 + exhibiting brands from over 135 countries.

Unigen logo

Press Release – Unigen Director of Pre-Clinical Development Elected to IASC Board

June 10, 2022

Unigen Inc. has announced that Dr. Mesfin Yimam, DVM, MS has been elected for a 3-year term to the International Aloe Science Council (IASC) Board of Directors.

Unigen logo

Press Release – Unigen announces Newest Ingredients

February 24, 2022

Unigen Inc. will introduce two new botanical ingredients at this year’s Natural Products Expo West in Anaheim. The new ingredients in Unigen’s botanical suite are Attenutin TM for respiratory health, and Symetrian TM for immune homeostasis.

Unigen logo

Maizinol™ for Sleep/Stress and UP360 for Immune Homeostasis

September 28, 2021

Unigen will introduce its two newest botanical ingredients for sleep/stress and immune health at this year’s SupplySide West Presentation Theater. Featured are Maizinol™, a natural alternative to melatonin, and UP360 for maintaining immune homeostasis.

Unigen logo

Dr. Qi Jia, Ph.D., named President & CEO, Unigen, Inc.

August 3, 2021

Dr. Jia has worked for the company 25 years since Unigen’s inception in 1996. The promotion to President & CEO is part of Unigen’s succession planning and positioning for its future and rapid growth.

Unigen logo

Regan Miles named Vice Chairman, Unigen, Inc.

August 3, 2021

Mr. Miles has 30+ years of experience in the natural products industry. He has held top leadership positions with many of the leading companies in the industry including Nature’s Way, Pharmanex, Integrative Therapeutics, Univera and Next Pharmaceuticals.

Unigen logo

Unigen’s Anivestin™ and AmLexin® for Joint Health of Companion Animals

January 28, 2020

Dr. Yimam presented “Botanical Alternatives for Reducing Inflammation and Protecting Cartilage in Cats and Dogs” during the January 21st breakfast session hosted by VetriScience Laboratories. The presentation highlighted the efficacy and safety of Unigen’s patented animal joint care ingredients, Anivestin™ and AmLexin®, clinically proven to reduce symptoms of inflammation – discomfort, stiffness and to protect joint cartilage degradation as experienced with osteoarthritis.

Unigen logo

AmLexin™ Studies for Delayed Onset Muscle Soreness and Joint Health

March 2019

Two recently concluded studies on Unigen’s joint health ingredient AmLexin™ have been published with particular recognition in scientific periodicals Nutrition and the Journal of Exercise Nutrition and Biochemistry. AmLexin™ is a patented botanical composition that contains a standardized blend of bioflavonoids from the heartwood of Acacia catechu and the root bark of Morus alba.

Unigen logo

Unigen’s UP1307 Skin Cream Excels in Clinical Trials

August 2018

Significant clinical results indicate Unigen’s newest skin care ingredient, UP1307, is effective in promoting skin hydration, firmness, and elasticity, with associated improvement in cellulite appearance. In the recently concluded clinical trial, UP1307 resulted in visibly superior results compared to similar cellulite products…

Unigen logo

Research Abstract Presented at 2018 Annual ASP Meeting: Triterpenoid Saponins from the Roots of Glycyrrhiza Glabra

July 2018

With a rising consumer demand for reduced-sugar in food and beverages, the discovery of natural low-/zero- calorie sugar alternatives brings more attention to global food industries and researchers. Licorice, the root of Gly­cyrrhiza species is one of the oldest and well-known sweet materials in the world. Glycyrrhizin as one of the major metabolites obtained from Licorice, is up to 50 times as sweet as sucrose, and is approved as a natural sweetener and/or flavor in many countries.

Unigen logo

New AmLexin™ data validates increased exercise recovery and reduced DOMS

March 2018

Unigen’s next generation joint protection product AmLexin™ has been clinically proven to aggressively support exercise recovery and within 1 to 3 days reduce delayed onset of muscular soreness post-exercise in healthy adults…

Univestin®

Health Canada Approves Fast Acting Health Claims for Univestin®

September 2017

Unigen’s superior regulatory and science teams are adding value to Canadian market joint care brands with the announcement of Health Canada’s approval of 3 day and 5 day fast acting health claims for Univestin®, Unigen’s premier joint health ingredient…

Unigen logo

Unigen and Institute of Chinese Materia Medica collaborate on DNA barcoding of PhytoLogix™ plants

September 2017

Unigen is partnering with China’s top tier Institute of Chinese Materia Medica to complete DNA barcoding of botanicals and marines in Unigen’s proprietary PhyoLogix™ collection…

Univestin®

New Publication on Univestin® Looks at Effects on Specific Systems

April 2016

Unigen, Inc. has published a study showing Univestin has no adverse effects on the Cardiovascular, Respiratory and Central Nervous Systems…

Univestin®

Extensive Safety Testing Continues for Univestin®

March 2016

Unigen, Inc. publishes extensive 26-week toxicity study; providing further validation for Univestin’s long-term safety…

Unigen logo

New Developments in Joint Health Provided by Unigen, Inc.

February 2016

Unigen, Inc. continues to fulfill their mission to bring the best of nature to humankind with new ingredients offerings and more research.

Univestin®

Unigen Announces Relaunch of Univestin®

August 2015

Univestin® proprietary joint health ingredient debuts with new branding, logo, marketing materials all designed to promote the Univestin Triple Play: Accelerated Action, Lasting Comfort, Long-term Safety…

Univestin®

Univestin® Reproductive Toxicity Studies Published

August 2015

Unigen continues to add to the extensive body of research surrounding Univestin®, their innovative joint health ingredient, with new studies on the effects of the compound on reproduction in rats. Unigen performed 3 separate but related studies, labeled as Part-I through III. Each part addresses a different aspect of fertility, reproduction and development…

Unigen logo

Unigen Hires Vice President of Sales & Marketing

June 2015

Unigen, Inc. announced today that Grant Bergstrom joined the company to help further expand the awareness and distribution of the firm’s scientifically proven ingredients.

Unigen logo

Rodney Storms Hiring Announcement

June 2015

Unigen, Inc. announced today that Rodney Storms joined the company as Regional Sales Director…

Unigen logo

Regan Miles Joins as CEO

April 2015

Unigen, Inc. announced today that Regan Miles has been selected to lead the company as President and CEO.